March 14, 2018 / 11:53 AM / in 37 minutes

BRIEF-Proteostasis Therapeutics Sees Cash, Cash Equivalents Balance As Of Dec 31, Sufficient To Fund Operations Into Early 2019

Reuters Staff

1 Min Read

March 14 (Reuters) - Proteostasis Therapeutics Inc:

* PROTEOSTASIS THERAPEUTICS INC - CO ESTIMATES CASH, CASH EQUIVALENTS BALANCE AS OF DEC 31, 2017, SUFFICIENT TO FUND OPERATIONS INTO EARLY 2019 Source text: (bit.ly/2FWFOfk) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

BRIEF-Proteostasis Therapeutics Sees Cash, Cash Equivalents Balance As Of Dec 31, Sufficient To Fund Operations Into Early 2019​

BRIEF-Proteostasis Therapeutics Sees Cash, Cash Equivalents Balance As Of Dec 31, Sufficient To Fund Operations Into Early 2019